Dianthus Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+1.90%
vs ±9.7% implied · ×0.20
shaded = implied · ▲▼ = realized
Fund move
Fund move
No thesis.
Dianthus Therapeutics, Inc.
82.00
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $799.3M | 12.38% | +5.56% | |
| 2 | BlackRockBlackRockindex-like | $402.0M | 6.23% | +29.86% | |
| 3 | T. Rowe Price Investment ManagementT. Rowe Price | $379.0M | 5.87% | +200.92% | |
| 4 | Wellington Management GroupWellington | $314.8M | 4.88% | +24.43% | |
| 5 | Fairmount Funds ManagementFairmount Funds | $247.3M | 3.83% | 0.00% | |
| 6 | T. Rowe Price AssociatesT. Rowe Price | $245.2M | 3.80% | +119.27% | |
| 7 | State StreetState Streetindex-like | $229.8M | 3.56% | +68.52% | |
| 8 | Vanguard Capital ManagementVanguardindex-like | $210.5M | 3.26% | +6.32% | |
| 9 | Avidity Partners ManagementAvidity Partners | $205.1M | 3.18% | 0.00% | |
| 10 | Octagon Capital AdvisorsOctagon Capital | $179.5M | 2.78% | −5.39% | |
| 11 | TCG Crossover ManagementTCG Crossover | $163.4M | 2.53% | 0.00% | |
| 12 | Fred Alger ManagementFred Alger | $127.0M | 1.97% | +12.10% | |
| 13 | Geode Capital ManagementGeodeindex-like | $122.7M | 1.90% | +37.36% | |
| 14 | VR AdviserVR Adviser | $115.0M | 1.78% | 0.00% | |
| 15 | UBS GroupUBS | $111.2M | 1.72% | +45.95% | |
| 16 | Deerfield ManagementDeerfield | $109.7M | 1.70% | +10.35% | |
| 17 | Citadel AdvisorsCitadel | $100.0M | 1.55% | −37.79% | |
| 18 | Jennison AssociatesJennison | $99.6M | 1.54% | +110.61% | |
| 19 | Polar Capital HoldingsPolar Capital | $99.3M | 1.54% | −5.32% | |
| 20 | Franklin ResourcesFranklin Resources | $94.5M | 1.46% | +0.08% | |
| 21 | Baker Bros. AdvisorsBaker Bros. | $83.1M | 1.29% | 0.00% | |
| 22 | AlliancebernsteinAlliancebernstein | $81.3M | 1.26% | −9.93% | |
| 23 | Logos Global ManagementLogos Global | $78.0M | 1.21% | +100.00% | |
| 24 | Cormorant Asset ManagementCormorant | $73.1M | 1.13% | −21.05% | |
| 25 | BraidwellBraidwell | $58.0M | 0.90% | −33.89% |
269 managers report $6.5B of Dianthus Therapeutics on form 13F for the quarter ended Jun 30 '26. 36 of them hold 80% of it; FMR is largest at 12.38%.
Largest filed tie
—
Expected move
Inputsspot 82.38exp Nov 20ATM strike 80ATM straddle 10.22IV 65%